Serge Saxonov, Chief Executive Officer at 10x Genomics, Inc. (TXG), sold 28,893 shares at $24.44 ($709K) on 2026-05-22, disclosed to the SEC on 2026-05-27.
Scheduled sale ($709k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.44 | 18,175 | $444K | 62.6% |
| 2 | $24.71 | 10,718 | $265K | 37.4% |
| Total | $24.54 avg | 28,893 | $709K | 100% |
| Filing → |
| TXG | SELL | 2026-08-26 | $1.2M | — | Filing → |
| TXG | SELL | 2026-06-24 | $1.0M | — | Filing → |
| TXG | SELL | 2026-04-16 | $123K | — | Filing → |